Benoit Dumont
Overview
Explore the profile of Benoit Dumont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bobin C, Iddir Y, Butterworth C, Masliah-Planchon J, Saint-Charles A, Bellini A, et al.
Clin Cancer Res
. 2024 May;
30(15):3316-3328.
PMID: 38787533
Purpose: The study of cell-free DNA (cfDNA) enables sequential analysis of tumor cell-specific genetic alterations in patients with neuroblastoma. Experimental Design: Eighteen patients with relapsing neuroblastoma having received lorlatinib, a...
2.
Magnier O, Schiff I, Cristante J, Chabre O, Veloso M, Bosson J, et al.
Pediatr Blood Cancer
. 2024 May;
71(8):e31074.
PMID: 38778452
Background: Adult- and adolescent-onset neuroblastomas are rare, with no established therapy. In addition, rare pheochromocytomas may harbor neuroblastic components. This study was designed to collect epidemiological, diagnostic and therapeutic data...
3.
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles A, Thebaud E, et al.
Eur J Cancer
. 2024 Mar;
202:114001.
PMID: 38489858
Background: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this...
4.
Su X, Lu X, Bazai S, Dainese L, Verschuur A, Dumont B, et al.
Nat Commun
. 2023 Nov;
14(1):7884.
PMID: 38036539
Wilms tumors are highly curable in up to 90% of cases with a combination of surgery and radio-chemotherapy, but treatment-resistant types such as diffuse anaplastic Wilms tumors pose significant therapeutic...
5.
Lacerda A, Aviles Martinez M, Dumont B, Leiss U, Kokkinou G, Scheinemann K, et al.
Pediatr Blood Cancer
. 2023 Jul;
70(10):e30561.
PMID: 37430425
Paediatric palliative care aims to support children and young people with life-limiting or life-threatening conditions, and their families, from the time of diagnosis. Early integration within oncology has been recognised...
6.
Irtan S, Coulomb-LHermine A, Lanz C, Tabone M, Pasqualini C, Dumont B, et al.
Pediatr Blood Cancer
. 2022 Dec;
70(3):e30107.
PMID: 36453594
Aim: The number of lymph nodes (LN) that should be sampled during nephrectomy for Wilms tumour (WT) remains controversial but of utmost importance for staging purposes. The aim of this...
7.
Hont A, Dumont B, Sutton K, Anderson J, Kentsis A, Drost J, et al.
Pediatr Blood Cancer
. 2022 Dec;
70 Suppl 2:e30110.
PMID: 36451260
This review highlights the role of several immunomodulating elements contributing to the tumor microenvironment of various pediatric renal tumors including Wilms tumor. The roles of innate and adaptive immune cells...
8.
Jouglar E, Laprie A, Isfan F, Dumont B, Thebaud E, Escande A, et al.
Pediatr Blood Cancer
. 2022 Sep;
69(12):e29950.
PMID: 36057861
Objective: To describe locoregional failure (LRF) after postoperative flank radiotherapy (RT) among French patients with nephroblastoma included in the Société Internationale d'Oncologie Pédiatrique (SIOP)-2001 protocol. Patients And Methods: In selected...
9.
Lemelle L, Moya-Plana A, Dumont B, Fresneau B, Laprie A, Claude L, et al.
Bull Cancer
. 2022 Apr;
109(4):491-504.
PMID: 35428456
Background: NUT carcinoma (NC), defined by the presence of the NUTM1 rearrangement, is an aggressive tumour associated with poor prognosis. This rare cancer is underdiagnosed and difficult to treat. Objective...
10.
Collignon C, Brisse H, Lemelle L, Cardoen L, Gauthier A, Pierron G, et al.
Bull Cancer
. 2020 Sep;
107(10):963-971.
PMID: 32950242
Soft tissue sarcomas in children are rare tumor, representing around 6 to 7% of children cancer. They spread mostly sporadically (90%) and therefore are rarely associated to an underlying constitutional...